Notably, Cohort 1 demonstrated a 66 percent inhibition of miR-10b at 24 hours post-infusion, which is similar to previous findings, and Cohort 2 showed increased activity with the higher dose ...
Preliminary analyses indicate that TTX-MC138 has demonstrated pharmacodynamic activity, with a 66% inhibition of miR-10b expression at 24 hours post-infusion, similar to findings from the earlier ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback